The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-(3'-(Aminomethyl)-4'-chloro-[1,1'-biphenyl]-3-carboxamido)phenyl)acetic acid ID: ALA4743401
PubChem CID: 162646617
Max Phase: Preclinical
Molecular Formula: C22H19ClN2O3
Molecular Weight: 394.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NCc1cc(-c2cccc(C(=O)Nc3ccccc3CC(=O)O)c2)ccc1Cl
Standard InChI: InChI=1S/C22H19ClN2O3/c23-19-9-8-15(11-18(19)13-24)14-5-3-6-17(10-14)22(28)25-20-7-2-1-4-16(20)12-21(26)27/h1-11H,12-13,24H2,(H,25,28)(H,26,27)
Standard InChI Key: ZFAJPOLKQKSTMN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
23.8787 -9.8310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8776 -10.6506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5856 -11.0595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2953 -10.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2925 -9.8274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5838 -9.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5873 -11.8745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8779 -12.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8773 -13.0988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5855 -13.5084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2956 -13.0956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2927 -12.2805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9986 -9.4162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7079 -9.8221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9955 -8.5990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.5864 -14.3256 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
27.4140 -9.4108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1217 -9.8202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8274 -9.4096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8247 -8.5915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1105 -8.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4078 -8.5987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1227 -10.6373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8310 -11.0450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8320 -11.8622 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5382 -10.6355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.0047 -13.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7110 -13.0909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
5 13 1 0
13 14 1 0
13 15 2 0
10 16 1 0
14 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
23 24 1 0
24 25 2 0
24 26 1 0
11 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 394.86Molecular Weight (Monoisotopic): 394.1084AlogP: 4.35#Rotatable Bonds: 6Polar Surface Area: 92.42Molecular Species: ZWITTERIONHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.77CX Basic pKa: 8.95CX LogP: 1.82CX LogD: 1.81Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.08
References 1. Velcicky J,Wilcken R,Cotesta S,Janser P,Schlapbach A,Wagner T,Piechon P,Villard F,Bouhelal R,Piller F,Harlfinger S,Stringer R,Fehlmann D,Kaupmann K,Littlewood-Evans A,Haffke M,Gommermann N. (2020) Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure., 63 (17): [PMID:32856916 ] [10.1021/acs.jmedchem.0c01020 ]